Neuphoria Therapeutics In...

5.04
-0.15 (-2.89%)
At close: Apr 25, 2025, 3:59 PM
5.04
0.00%
After-hours: Apr 25, 2025, 04:00 PM EDT

Neuphoria Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021 Jun 30, 2020 Jun 30, 2019 Jun 30, 2018 Jun 30, 2017
-15.49M -21.38M -14.97M -6.53M -4.89M n/a n/a n/a
662.99K 663.19K 763.17K 1.28M 1.68M n/a n/a n/a
814.81K 1.35M 1.95M 983.01K 38.03K n/a n/a n/a
351.28K 447.29K 157.44K -294.75K 83.39K n/a n/a n/a
-2.12M 150.97K 1.15M -2.62M -2.28M -10.91M -15.02M -1.44M
n/a n/a n/a n/a n/a n/a n/a n/a
1.45M 4.58M -3.85M 1.23M 2.77M n/a n/a n/a
-14.68M -14.64M -14.97M -5.66M -2.68M -10.91M -15.02M -1.44M
n/a n/a -1.06K -1.1K -5.29K -69.28K -358.11K -190.2K
n/a n/a n/a n/a -692.61K n/a n/a n/a
n/a n/a n/a -89.01K -35.85K n/a n/a n/a
n/a n/a 299.68K n/a 377.92K n/a n/a n/a
n/a 317.41K 129.06K 29.85K 221.76K 207.71K 417.79K 923.25K
n/a 317.41K 427.68K -60.26K -134.08K 138.42K 59.68K 733.05K
n/a -105.94K -119.85K -8.92M -5.69M -3.73M 1.63M -1.71M
n/a n/a n/a -415.48K -48.23K -420.37K n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
5M 105.94K -3.94M -312.16K -226.68K -294.4K 1.00 0.02
15.11M 3.86M 18.57M 23.71M -3.68M 3.05M 1.94M -1.6M
504.99K -11.02M 3.48M 17.97M -6.46M -7.67M -13.18M -1.98M
-14.68M -14.64M -14.97M -5.67M -2.69M -10.98M -15.38M -1.3M